We are excited to announce the release of the Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Benzodiazepine Risks Outweigh Benefits, funded by the FDA. This Guideline was developed through a partnership of 10 medical and professional societies, including AAPP. A special thank you to Amy VandenBerg, PharmD, BCPP, FAAPP, AAPP’s representative on the guidelines work group.